Tan, C., Zhang, A., Chen, H. & Zhou, R. Recent proceedings on prevalence and pathogenesis of Streptococcus suis. Curr. issues Mol. Biol. 32, 473–520 (2019).

Article  PubMed  Google Scholar 

Segura, M. Streptococcus suis research: progress and challenges. Pathogens 9, 707 (2020).

Bonifait, L., Veillette, M., Létourneau, V., Grenier, D. & Duchaine, C. Detection of Streptococcus suis in bioaerosols of swine confinement buildings. Appl. Environ. Microbiol. 80, 3296–3304 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Dutkiewicz, J. et al. Streptococcus suis: a re-emerging pathogen associated with occupational exposure to pigs or pork products. Part II - pathogenesis. Ann. Agric. Environ. Med. AAEM 25, 186–203 (2018).

Article  CAS  PubMed  Google Scholar 

Dong, X. et al. The global emergence of a novel Streptococcus suis clade associated with human infections. EMBO Mol. Med. 13, e13810 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng, Y., Zhang, H., Ma, Y. & Gao, G. F. Uncovering newly emerging variants of Streptococcus suis, an important zoonotic agent. Trends Microbiol. 18, 124–131 (2010).

Article  CAS  PubMed  Google Scholar 

Segura, M. et al. Update on Streptococcus suis research and prevention in the era of antimicrobial restriction: 4th international workshop on S. suis. Pathogens (Basel, Switzerland) 9, 374 (2020).

Bojarska, A. et al. Diversity of serotypes and new cps loci variants among Streptococcus suis isolates from pigs in Poland and Belarus. Vet. Microbiol. 240, 108534 (2020).

Article  CAS  PubMed  Google Scholar 

Zhu, J. et al. Streptococcus suis serotype 4: a population with the potential pathogenicity in humans and pigs. Emerg. microbes Infect. 13, 2352435 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Goyette-Desjardins, G., Auger, J. P., Xu, J., Segura, M. & Gottschalk, M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. microbes Infect. 3, e45 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Kang, W. et al. Investigation of genomic and pathogenicity characteristics of Streptococcus suis ST1 human strains from Guangxi Zhuang Autonomous region (GX) between 2005 and 2020 in China. Emerg. Microbes Infect. 13, 2339946 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Maneerat, K. et al. Virulence genes and genetic diversity of Streptococcus suis serotype 2 isolates from Thailand. Transbound. Emerg. Dis. 60, 69–79 (2013).

Article  PubMed  Google Scholar 

Atanassov, C., Bonifait, L., Perivier, M., Gottschalk, M. & Grenier, D. Candidate proteomic biomarkers for three genogroups of the swine pathogen Streptococcus suis serotype 2. BMC Microbiol. 15, 84 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Segura, M. Streptococcus suis vaccines: candidate antigens and progress. Expert Rev. Vaccines 14, 1587–1608 (2015).

Article  CAS  PubMed  Google Scholar 

Fan, Q., Wang, H., Wang, Y., Yi, L. & Wang, Y. Evaluation of the protective efficacy of three novel identified membrane associated proteins of Streptococcus suis serotype 2. Micro. Pathog. 193, 106759 (2024).

Article  CAS  Google Scholar 

Yi, L. etal. Evaluation of immune effect of Streptococcus suis biofilm-associated protein PDH. Vet. Microbiol 263, (2021).

Wang, H., Fan, Q., Wang, Y., Yi, L. & Wang, Y. Rethinking the control of Streptococcus suis infection: Biofilm formation. Vet. Microbiol. 290, 110005 (2024).

Article  CAS  PubMed  Google Scholar 

Wang, J. et al. Identification of a novel linear B cell epitope on the sao protein of Streptococcus suis serotype 2. Front. Immunol. 11, 1492 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Li, W., Wan, Y., Tao, Z., Chen, H. & Zhou, R. A novel fibronectin-binding protein of Streptococcus suis serotype 2 contributes to epithelial cell invasion and in vivo dissemination. Vet. Microbiol. 162, 186–194 (2013).

Article  CAS  PubMed  Google Scholar 

Ji, Y., Sun, K., Yang, Y. & Wu, Z. Dihydroartemisinin ameliorates innate inflammatory response induced by Streptococcussuis-derived muramidase-released protein via inactivation of TLR4-dependent NF-κB signaling. J. Pharm. Anal. 13, 1183–1194 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Garibaldi, M. et al. Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. Vaccine 28, 3609–3616 (2010).

Article  CAS  PubMed  Google Scholar 

Li, Q. et al. Identification of novel laminin- and fibronectin-binding proteins by far-western blot: capturing the adhesins of Streptococcus suis type 2. Front. Cell. Infect. Microbiol. 5, 82 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, Q. et al. Live attenuated salmonella enterica serovar choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice. Vaccine 38, 6904–6913 (2020).

Article  CAS  PubMed  Google Scholar 

Zhang, S. et al. Discovery of oligosaccharide antigens for semi-synthetic glycoconjugate vaccine leads against Streptococcus suis serotypes 2, 3, 9 and 14*. Angew. Chem. (Int. ed. Engl.) 60, 14679–14692 (2021).

Article  CAS  PubMed  Google Scholar 

Wisselink, H. J., Vecht, U., Stockhofe-Zurwieden, N. & Smith, H. E. Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet. Rec. 148, 473–477 (2001).

Article  CAS  PubMed  Google Scholar 

Li, Y. A. et al. Salmonella enterica serovar Choleraesuis vector delivering a dual-antigen expression cassette provides mouse cross-protection against Streptococcus suis serotypes 2, 7, 9, and 1/2. Vet. Res. 53, 46 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Tahir Ul Qamar, M. et al. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infect. Dis. poverty 9, 132 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Goodswen, S. J., Kennedy, P. J. & Ellis, J. T. A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery. FEMS Microbiol. Rev. 47, fuad004 (2023).

Albutti, A. An integrated multi-pronged reverse vaccinology and biophysical approaches for identification of potential vaccine candidates against Nipah virus. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 31, 101826 (2023).

CAS  Google Scholar 

Tang, X. D. et al. In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies. Cancer Sci. 105, 9–17 (2014).

Article  CAS  PubMed  Google Scholar 

Cong, H. et al. Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal toxoplasma gondii infection in mice. Parasit. Vectors 7, 145 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Zhu, S. et al. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice. Appl. Microbiol. Biotechnol. 98, 4107–4117 (2014).

Article  CAS  PubMed  Google Scholar 

Liao, J. et al. A rational designed multi-epitope vaccine elicited robust protective efficacy against Klebsiella pneumoniae lung infection. Biomed. Pharmacother. Biomed. Pharmacotherapie 174, 116611 (2024).

Article  CAS  Google Scholar 

Tahir Ul Qamar, M. et al. Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches. Comput. Biol. Med. 132, 104389 (2021).

Article  CAS  PubMed  Google Scholar 

Kalita, A., Kalita, M. & Torres, A. G. Exploiting the power of OMICS approaches to produce E. coli O157 vaccines. Gut Microbes 5, 770–774 (2014).

Article